Finance

Beta
Lists
NGEN:NASDAQ
NervGen Pharma Corp
$1.86
-7.46%
(-0.15) 1D
$1.88
+1.08% (+0.020)
Pre-market
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NGEN...
Open
$2.04
High
$2.05
Low
$1.85
Mkt. cap
152.88M
Avg. vol.
996.30K
Volume
250.00
52-wk high
$6.30
52-wk low
$1.85
EPS
-$0.41
Beta
0.70
Shares outstanding
80.93M
No. of employees
10
Open
$2.04
High
$2.05
Low
$1.85
Mkt. cap
152.88M
Avg. vol.
996.30K
Volume
250.00
52-wk high
$6.30
52-wk low
$1.85
EPS
-$0.41
Beta
0.70
Shares outstanding
80.93M
No. of employees
10
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to NGEN in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NGEN in the last 3 months.
Highest
Current $1.86
$18.00 (+867.74%)
Average
$11.90 (+539.78%)
Lowest
$5.50 (+195.70%)
News stories
From sources across the web
About NervGen Pharma Corp
CEO-
Employees10
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websitenervgen.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.71M
4.44M
3.60M
4.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.76M
1.73M
2.80M
2.67M
Operating expense
6.47M
6.17M
6.40M
7.53M
Total operating expenses
6.47M
6.17M
6.40M
7.53M
Operating income
-6.47M
-6.17M
-6.40M
-7.53M
Other non operating income
-2.70M
1.98M
-20.24M
5.72M
EBT including unusual items
-9.10M
-4.16M
-26.91M
-1.68M
EBT excluding unusual items
-9.10M
-4.16M
-26.91M
-1.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.10M
-4.16M
-26.91M
-1.68M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.06
-
-
Interest and investment income
86.90K
77.07K
61.68K
104.07K
Interest expense
-
-
-
-
Net interest expenses
86.90K
77.07K
61.68K
104.07K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.46M
-6.16M
-6.39M
-7.52M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer